High blood sugar levels and insulin treatment in preterm babies. The HINT trial.

Phase 4

Completed

• Conditions: eonatal Hyperglycaemia; Neonatal Hyperglycaemia; Reproductive Health and Childbirth - Complications of newborn; Blood - Other blood disorders

• Registration Number: ACTRN12606000270516
• Lead Sponsor: Dr Jane Alsweiler

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-04-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Babies <30 weeks gestation or <1500g and 2 consecutive blood glucose measurements of >8.5 mmol/l, 4 hours apart.

Exclusion Criteria

Hyperglycemia secondary to an accidental overdose. Babies with major congenital malformation. Imminent death

Study & Design

• Study Type: Interventional
• Study Design: Not specified